lilly glp-1 pill Eli to seek approval of new weight-loss drug this year Eli Lilly's Obesity Pill Appears

Our healthcare team provides clear and personalized instructions to ensure you administer your medication correctly and safely

Some companies are looking beyond GLP-1 and other hot targets like GIP and glucagon to emerging areas like amylin, another hormone produced in the pancreas that helps people feel full

But it's also more expensive and can cause more side effects

Your stance on weight loss drugs, like any new technology, should be rooted in how you approach other benefits for your team

Unlike older antidepressants that affect multiple brain chemicals, it specifically targets serotonin reuptake

It is also unclear whether Part D plan sponsors would be able continue to cover GLP-1 drugs for the treatment of obesity once the model ended if Medicares statutory exclusion on weight loss drugs is not lifted